Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

NCT00003662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes
Thymic Carcinoma

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: melphalan
DRUG: methylprednisolone
PROCEDURE: umbilical cord blood transplantation
RADIATION: radiation therapy

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]